Skin tumors in photochemotherapy for psoriasis: A single-center follow-up of 496 patients?

Dermatology

Volumn 193, Issue 3, 1996, Pages 185-191

  Maier, H ^a   Schemper, M ^b   Ortel, B ^a   Binder, M ^c   Tanew, A ^a   Honigsmann H ^a  

^a Division of Special and Environmental Dermatology   (Austria)

^b Section of Clinical Biometrics   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Nonmelanoma skin cancer; Photochemotherapy; Psoralen

Indexed keywords

ARSENIC; METHOTREXATE; PSORALEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; REGRESSION ANALYSIS; RISK FACTOR; SCHOOL CHILD; SKIN CANCER; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET A RADIATION;

EID: 0029825717     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246243     Document Type: Article

References (36)

1. Parrish JA. Fitzpatrick TB. Tanenbaum L. Pathak MA: Photochemotherapy of psoriasis with oral mcthoxsalcn and longwave ultraviolet light. N Engl J Med 1974;291:1207-1222.
2. Dall'Acqua F. Marciani S. Ciavatta I. Rodi-ghiero G: Formation of interstrand cross-linkings in the photoreactions between furocou-niarins and DNA. Z Naturforseh (B) 1971: 26:561-569.
3. Ortel B. Gange RW: An action spectrum for the elicitation of erythema in skin persistently sensitized by photobound 8-melhoxypsoralen. J Invest Dermatol 1990:94:781-785.
4. O’Neal MA, Griffin AC: The effect of oxypso-ralen upon ultraviolet carcinogenesis in albino mice. Cancer Res 1957;17:911-916.
5. Hakim RE. Griffin AC. Knox JM: Erythema and tumor formation in methoxsalen-treated mice exposed to fluorescent light. Arch Dermatol 1960:82:572-577.
6. Forbes PD. Davies RE. Urbach R: Phototoxicity and photocarcinogenesis: Comparative effects of anthracene and 8-mclhoxypsoralen in the skin of mice. Fed Cosmet Toxicol 1976;14:303-306.
7. Dunnick JK. Forbes PD. Eustis SL, Hardisty JF, Goodman DG: Tumors of the skin in the HRA/Skh mouse after treatment with 8-me-thoxypsoralen and UVA radiation. Fundam Appl Toxicol 1991; 16:92-102.
8. Stern RS. Thibodeau LA, Kleinerman RA. Parrish JA, Fitzpatrick TB. and 22 participating members: Risk of cutaneous carcinoma in patients treated with oral mcthoxsalen photo-chemotherapy for psoriasis. N Engl J Med 1979;300:809-813.
9. Hönigsmann H. Wolff K. Gschnail F. Brenner W. Jaschkc E: Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA). J Am Acad Dermatol 1980:3: 406-414.
10. Roenigk HH. Caro WA: Skin cancer in the PUVA-48 cooperative study. J Am Acad Dermatol 1981:4:319-324.
11. Lindskov R: Skin carcinomas and treatment with photochemotherapy (PUVA). Acta Derm Venereol (Stockh) 1983;63:223-226.
12. Henselcr T, Christophers E: Risk of skin tumors in psoralen- and ultraviolet A-treatcd patients. Natl Cancer Inst Monogr 1984:66: 217-219.
13. Rcshad H. Challoner F. Pollock DJ. Baker H: Cutaneous carcinoma in psoriatic patients treated with PUVA. Br J Dermatol 1984:110: 299-305.
14. Stern RS. Laird N. Melski J. Parrish JA. Fitzpatrick TB. Bleich HL: Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-1161.
15. Eskelincn A. Halme K. Lassus A. Idänpäün-Heikkilä J: Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatology 1985:2:10-14.
16. Henseler T. Christophers E. Hönigsmann H. Wolff K. and 19 other investigators: Skin tumors in the European PUVA study. J Am Acad Dermatol 1987:16:108-116.
17. Torinuki W. Tagami H: Incidence of skin cancer in Japanese psoriatic patients treated with cither mcthoxsalen phototherapy. Goeckerman regimen or both therapies. J Am Acad Dermatol 1988:18:1278-1281.
18. Forman AB. Roenigk HH. Caro WA. Magid ML: Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol 1989:125:515-519.
19. Bruynzcel I. Bergman W. Harteveit HM. Ken-ter CCA. Van de Velde EA. Schothorst AA. Suurnond D: High single-dose European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol 1991; 124:49-55.
20. Lindelöf B. Sigurgeirsson B. Tegner E. Larkö Johanneson A. Berne B. Christensen OB. Anderson T. Törngren M. Mol in L. Nylandcr-Lundquist E. Emtestan L: PUVA and cancer: A large-scale epidemiological study. Lancet 1991:338:91-93.
21. Chuang T. Heinrich LA. Schultz VID. Reizner GT. Kumm RC. Cripps DJ: PUVA and skin cancer. J Am Acad Dermatol 1992:26:173-177.
22. Olsen JH. Möller H. Frentz G: Malignant tumors in patients with psoriasis. J Am Acad Dermatol 1992:27:716-722.
23. Tanew A. Hönigsmann H. Ortel B. Zussner C. Wolff K: Nonmelanoma skin tumors in longterm photochemotherapy treatment of psoriasis. J Am Acad Dermatol 1986; 15:960-965.
24. Lever LR. Farr PM: Skin cancers or prcmalig-nant lesions occur in half of high-dose PUVA patients. BrJ Dermatol 1994:131:215-219.
25. Cox DR: Regression models and life tables. J R Stat Soc 1972:834:187-220.
26. Dixon WJ: BMDP Statistical Software Manual. Berkeley. University of California Press. 1990.
27. Schemper M: The relative importance of prognostic factors in studies of survival. Stat Med 1993:12:2377-2382.
28. Henseler T. Honigsmann H. Wolff K. Christophers E: Oral 8-methoxypsoralen photo-chemotherapy of psoriasis. The European PUVA Study: A cooperative study among 18 European centres. Lancet 1981;i:853-857.
29. Karagas MR. Stukel TA. Greenberg ER. Baron JA. Mott LA. Stern RS for the skin cancer prevention study group: Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992;267:3305-3310.
30. Lewis FM, Shak M, Messenger AG. Thomas WEG: Metastatic squamous cell carcinoma in patient receiving PUVA. Lancet 1994:344: 1157.
31. Gibbs NK. Honigsmann H. Young AR: PUVA treatment strategics and cancer risk. Lancet 1986: i: 150-151.
32. Young AR: Photocarcinogenicity of psoralens used in PUVA treatment: Present status in mouse and man. J Photochem Photobiol 1990; 6:237-247.
33. Stern RS, Laird N. for the photochemotherapy follow-up study: The carcinogenic risk of treatments for severe psoriasis. Cancer 1994:73: 2759-2764.
34. Stern RS, and members of the photochemotherapy follow-up study: Genital tumors among men with psoriasis exposed to psoralen and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990:322: 1093-1097.
35. Wikifang H. Jacobsen FK. Thcstrup-Pedersen K: PUVA treatment of vitiligo: A retrospective study of 59 patients. Acta Derm Venereol (Stockh) 1992:72:305-306.
36. Harris! TJ. Pathak MA. Mosher DB, Fitzpatrick TB: Chronic cutaneous effects of longterm psoralen and ultraviolet radiation therapy in patients with vitiligo. Natl Cancer Inst Monogr 1984:66:191-196.